Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Cerebral Adrenoleukodystrophy: Effects of Donor Cell Source and Match, Conditioning Regimen, and Stage of Cerebral Disease
Jaap Jan Boelens(Wilhelmina Children's Hospital), Paul J. Orchard(University of Minnesota), Alison Timm(Bluebird Bio (United States)), Jörn‐Sven Kühl(Charité - Universitätsmedizin Berlin), Simon A. Jones(Cardiff University), Caroline A. Lindemans(University Medical Center Utrecht), Mattia Algeri, Caroline Sevin(Bicêtre Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Esther Shamir(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Robert Chiesa(Great Ormond Street Hospital), Neena Kapoor(University of Southern California), Andrew C. Dietz(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Elizabeth McNeil(Bluebird Bio (United States)), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Nancy Bunin(University of Iowa), Hernán Amartino(Manchester Royal Eye Hospital), Vinod K. Prasad(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
Cited by 0
Related Papers
Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6
|The Journal of Immunology|2005|764
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
|Journal of Clinical Investigation|2011|677